127 related articles for article (PubMed ID: 23352642)
21. F-box protein Skp2: a novel transcriptional target of E2F.
Zhang L; Wang C
Oncogene; 2006 Apr; 25(18):2615-27. PubMed ID: 16331253
[TBL] [Abstract][Full Text] [Related]
22. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
[TBL] [Abstract][Full Text] [Related]
23. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors.
Salon C; Merdzhanova G; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2007 Oct; 26(48):6927-36. PubMed ID: 17471231
[TBL] [Abstract][Full Text] [Related]
24. The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.
Li L; Liu B; Zhang X; Ye L
Biochem Biophys Res Commun; 2015 Mar; 458(3):720-725. PubMed ID: 25686500
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-205-5p targets E2F1 to promote autophagy and inhibit pulmonary fibrosis in silicosis through impairing SKP2-mediated Beclin1 ubiquitination.
Qian Q; Ma Q; Wang B; Qian Q; Zhao C; Feng F; Dong X
J Cell Mol Med; 2021 Oct; 25(19):9214-9227. PubMed ID: 34428336
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
[TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
Reichert M; Saur D; Hamacher R; Schmid RM; Schneider G
Cancer Res; 2007 May; 67(9):4149-56. PubMed ID: 17483325
[TBL] [Abstract][Full Text] [Related]
28. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
[TBL] [Abstract][Full Text] [Related]
29. [Over-expression of human S-phase kinase-associated protein 2 (Skp2) promotes proliferation of MCF-7 breast cancer cells and increases the number of S phase cells].
Yang C; Nan K; Qin S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Oct; 31(10):1306-10. PubMed ID: 26429528
[TBL] [Abstract][Full Text] [Related]
30. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
31. Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity.
Lu Z; Bauzon F; Fu H; Cui J; Zhao H; Nakayama K; Nakayama KI; Zhu L
Nat Commun; 2014 Mar; 5():3463. PubMed ID: 24632684
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B x-interacting protein induces HepG2 cell proliferation through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Wang FZ; Fei HR; Lian LH; Wang JM; Qiu YY
Exp Biol Med (Maywood); 2011 Jan; 236(1):62-9. PubMed ID: 21239735
[TBL] [Abstract][Full Text] [Related]
33. ERα, SKP2 and E2F-1 form a feed forward loop driving late ERα targets and G1 cell cycle progression.
Zhou W; Srinivasan S; Nawaz Z; Slingerland JM
Oncogene; 2014 May; 33(18):2341-53. PubMed ID: 23770852
[TBL] [Abstract][Full Text] [Related]
34. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
35. USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
Tan Y; Zhou G; Wang X; Chen W; Gao H
Int J Oncol; 2018 Jul; 53(1):371-383. PubMed ID: 29749454
[TBL] [Abstract][Full Text] [Related]
36. Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse transcriptase in human mesenchymal stem cells.
Wang FZ; Sha L; Ye LH; Zhang XD
Acta Pharmacol Sin; 2008 Jan; 29(1):83-9. PubMed ID: 18158869
[TBL] [Abstract][Full Text] [Related]
37. The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells.
Zhang Y; Zhao Y; Li H; Li Y; Cai X; Shen Y; Shi H; Li L; Liu Q; Zhang X; Ye L
J Biol Chem; 2013 Jun; 288(26):18961-74. PubMed ID: 23667255
[TBL] [Abstract][Full Text] [Related]
38. Suppression of HBXIP Reduces Cell Proliferation, Migration and Invasion In Vitro, and Tumorigenesis In Vivo in Human Urothelial Carcinoma of the Bladder.
Li X; Liu S
Cancer Biother Radiopharm; 2016 Nov; 31(9):311-316. PubMed ID: 27831760
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.
Cai X; Cao C; Li J; Chen F; Zhang S; Liu B; Zhang W; Zhang X; Ye L
Oncotarget; 2017 Aug; 8(35):58338-58352. PubMed ID: 28938560
[TBL] [Abstract][Full Text] [Related]
40. Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment.
Swarnalatha M; Singh AK; Kumar V
J Cell Sci; 2013 Oct; 126(Pt 20):4636-46. PubMed ID: 23868976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
